1 Matching Annotations
- Sep 2016
Without the tax-related reduction, Mylan’s profits on the EpiPen two-pack were about 60% higher than the figure given to Congress, or $166, it said in a new regulatory filing to the Securities and Exchange Commission Monday.
I chose this article to provide evidence that Mylan is raising the price way too much for the epipen. My inquiry question is how can a company justify raising the price of an item people need to survive an allergic reaction?